Evidence map›Paper›PMID 42240039›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2026

Engineering a High-Affinity Monoclonal Antibody for Thiram Immunoassays and Protection.

Linfang Lu, Kang Jiang, Na Li, Xiaoli Li, Lakshani Madushika, Sumei Ling, Shihua Wang

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Linfang LuThe Ministry of Education Key Laboratory of Biopesticide and Chemical Biology, Fujian Key Laboratory of Pathogenic Fungi and Mycotoxins, School of Life Sciences, and School of Animal Science, Fujian Agriculture and Forestry University, Fuzhou, China.ORCID https://orcid.org/0009-0001-6640-8282
Kang JiangThe Ministry of Education Key Laboratory of Biopesticide and Chemical Biology, Fujian Key Laboratory of Pathogenic Fungi and Mycotoxins, School of Life Sciences, and School of Animal Science, Fujian Agriculture and Forestry University, Fuzhou, China.
Na LiThe Ministry of Education Key Laboratory of Biopesticide and Chemical Biology, Fujian Key Laboratory of Pathogenic Fungi and Mycotoxins, School of Life Sciences, and School of Animal Science, Fujian Agriculture and Forestry University, Fuzhou, China.
Xiaoli LiThe Ministry of Education Key Laboratory of Biopesticide and Chemical Biology, Fujian Key Laboratory of Pathogenic Fungi and Mycotoxins, School of Life Sciences, and School of Animal Science, Fujian Agriculture and Forestry University, Fuzhou, China.
Lakshani MadushikaThe Ministry of Education Key Laboratory of Biopesticide and Chemical Biology, Fujian Key Laboratory of Pathogenic Fungi and Mycotoxins, School of Life Sciences, and School of Animal Science, Fujian Agriculture and Forestry University, Fuzhou, China.
Sumei LingThe Ministry of Education Key Laboratory of Biopesticide and Chemical Biology, Fujian Key Laboratory of Pathogenic Fungi and Mycotoxins, School of Life Sciences, and School of Animal Science, Fujian Agriculture and Forestry University, Fuzhou, China.ORCID https://orcid.org/0000-0002-0812-0037
Shihua WangThe Ministry of Education Key Laboratory of Biopesticide and Chemical Biology, Fujian Key Laboratory of Pathogenic Fungi and Mycotoxins, School of Life Sciences, and School of Animal Science, Fujian Agriculture and Forestry University, Fuzhou, China.

Funding

Instrumental Analysis Center of Fujian Agriculture and Forestry UniversityNational Key Research and Development Program of China 2023YFD1600503Promotion of Marine and fishery industries projects in Fujian Province FJHYF-L-2023-21
6 · The paper itself

Abstract

Thiram (TMTD), a widely used dithiocarbamate fungicide, provokes oxidative hepatotoxicity, yet practical strategies for its detection and immunoprotection remain scarce. Here we develop an antibody-enabled framework integrating detection, therapy, and prevention against TMTD. In the murine model, we characterized the dose-dependent hepatic injury induced by TMTD. Guided by rational C

Indexed as

Antibodies, MonoclonalAntibody AffinityThiramAnimalsImmunoassayLiverMiceAntibodies, MonoclonalThiramimmunoprotectionMOF‐based immunoassaymonoclonal antibodythiram

Identifiers

PMID42240039
PMCPMC13392691

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.